23 results on '"Koura, Divya"'
Search Results
2. Trial in Progress: Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
3. Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Shows Rapid Primary Engraftment with CD33-Negative Hematopoiesis in Patients with High-Risk Acute Myeloid Leukemia (AML) and Avoids Hematopoietic Toxicity during Gemtuzumab Ozogamicin (GO) Maintenance Post-Hematopoietic Cell Transplant (HCT).
4. The Impact of Social Determinants of Health on Brexucabtagene Autoleucel Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
5. NCCN Guidelines® Insights: Survivorship, Version 1.2023
6. P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS
7. Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients
8. MYOCARDIAL INFARCTION FROM CORONARY THROMBOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA
9. Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozogamicin (GO) in Patients with CD33+ Acute Myeloid Leukemia (AML) Who Are at High-Risk of Post-HCT Relapse
10. NCCN Guidelines® Insights: Survivorship, Version 1.2022
11. A Randomized Phase II Trial Comparing a Calcineurin Inhibitor-Free Graft-Versus-Host Disease Prophylaxis Regimen with Post-Transplantation Cyclophosphamide and Abatacept to Standard of Care
12. Survivorship, Version 1.2021
13. Long‐term Follow‐up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics
14. NCCN Guidelines Insights: Survivorship, Version 2.2020
15. Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma
16. NCCN Guidelines Insights: Survivorship, Version 2.2019
17. A Case of Aplastic Anemia Associated With Long-Term Metronidazole Use
18. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
19. Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
20. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire
21. Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
22. In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
23. Inherited predisposition to multiple myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.